University of Miami Sylvester Comprehensive Cancer Center
Avatar

COVID-19 Pandemic: Preparation Protocols, Telemedicine, and Modifying Treatment for Cancer Patients

By University of Miami Sylvester Comprehensive Cancer Center FEATURING Gilberto Lopes
April 1, 2020
10 Comments
Login to view comments. Click here to Login

Featured Video

12:13
Lilly

Efficacy of a Treatment in Combination With Endocrine-Based Therapy

Feat. M. Dietrich

Featured Video

06:28
Lilly

A Case Study of HR+, HER2- MBC With Rapid Progression

Feat. M. Dietrich

Related Content

AUTOPLAY
13:17
Platelet Disorder Support Association (PDSA)

COVID-19 Vaccine and Immune Thrombocytopenia

Feat. M. Beltrami-Moreira
21:42
UAB Hematology Review 2021

Hematologic Manifestations of COVID-19: Thrombosis Mechanisms and Risk, CO…

Feat. R. Gangaraju
25:05
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Adult Nursing Q&A Session: Autologous/Allogenic Transplant, COVID Mana…

Feat. P. Mangan, L. Perry, A. Walsh, A. Rubin, R. Golding, L. Quinn, K. Salam, K. Mcdevitt
47:07
Penn Medicine Abramson Cancer Center

Updates on Breast Care and Imaging During COVID-19: Vaccine-Related Axilla…

Feat. R. Jankowitz, E. Conant, T. D'Entremont, A. Steiner, J. Tchou
26:16
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Immunotherapy in Pediatric AML: CART33 Nursing Considerations During the P…

Feat. D. Baniewicz
17:06
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Pediatric CAR T-Cell Therapy During COVID-19: CHOP Experience

Feat. S. Maude
33:24
Zahra Pakbaz

Current Approach to Sickle Cell Anemia: COVID & SCD, Genotypes, Hemoly…

13:06
Cellicon Valley '21: The Future of Cell and Gene Therapies Virtual Symposium

Penn Medicine Q&A Panel on Cell Therapy During the COVID-19 Pandemic

Feat. D. Porter, C. Bollard, G. Shah, S. Maude, S. Devine
12:10
Penn Medicine Abramson Cancer Center

2021 Updates in Medical Oncology for Lung Cancer: Targeted Therapy, Tumor …

Feat. C. Aggarwal
21:47
Total Health Conferencing

Shared Expert Experience on the CML Management in the Time of COVID-19: Ho…

Feat. T. Kadia, F. Santos, H. Malhotra
10:25
Houston Methodist DeBakey Heart and Vascular Center

COVID-19 & Cytokine Storm: What Kind of Inflammatory Markers Are Relea…

Feat. J. Chang
09:15
8th Eurasian Hematology Oncology Summit

How I Treat ET in 2021: WHO True-ET, Thromboembolic/Bleeding Complications…

Feat. D. Wolf
13:34
UAB Hematology Review 2021

CLL Management in Times of COVID-19: Frontline Acalabrutinib or Ven +/- Ob…

Feat. M. Narkhede
15:32
Penn Medicine Abramson Cancer Center

COVID-19 Vaccination Guidelines for Our Cancer Patients: What Are the Elig…

Feat. L. Schuchter
25:06
2021 Virtual KU Hematology and Medical Oncology Review

ASCO 2021 Survivorship Highlights: Remote Symptom Monitoring, Inpatient Ca…

Feat. E. Wulff-Burchfield
16:58
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

Lessons Learned From irAE Management During COVID-19: Cytokine Storm, Impl…

Feat. L. Calabrese
04:06
Total Health Conferencing

Expert Experience on the CML Management in the Time of COVID-19: Preventio…

Feat. H. Malhotra
15:18
Memorial Sloan Kettering Cancer Center

MSKCC Updates on Telemedicine/Cohort Monitoring & COVID-19 Testing for…

Feat. D. Reidy-Lagunes
15:40
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases

COVID-19 & Hematologic Malignancies: What Is the Mortality Estimate Pe…

Feat. J. Leal
33:00
Total Health Conferencing

Will COVID-19 Leave Its Mark on Cancer Care?

Feat. G. Lopes